Hospital
ST Vincent Medical Center
ST Vincent Medical Center was paid $2.80M by Medicaid between Jan 2018 and Jan 2020, across 150 billing codes. Its largest line is 0450, Emergency room services — 19% of everything it billed.
33Billing provider infoST VINCENT MEDICAL CENTER
LOS ANGELES, CA 90057
LOS ANGELES, CA 90057
33aNPI1124004304assigned 12/19/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.80M
24GClaims150,157
24DCodes billed150
24AFirst – last monthJan 2018 – Jan 2020
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#249 of 410
Median peer was paid$6.90M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 84,324 | $1.49M | |
| 2019 | 64,676 | $1.29M | |
| 2020 | 1,157 | $19K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 19% | 12,316 | 10,769 | $529K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8.2% | 7,795 | 6,375 | $230K |
| Z7502 | 5.1% | 3,753 | 3,663 | $142K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.9% | 638 | 568 | $138K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.1% | 2,506 | 2,299 | $87K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.0% | 963 | 909 | $84K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 1,165 | 1,097 | $82K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.7% | 754 | 683 | $75K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.6% | 974 | 858 | $72K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.6% | 778 | 705 | $72K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 432 | 417 | $65K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.0% | 1,569 | 1,456 | $56K |
138 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.8% | 1,892 | $51K |
| 80053 | Comprehensive metabolic panel | 1.8% | 7,460 | $51K |
| 0301 | 1.8% | 426 | $51K | |
| 93000 | 1.8% | 2,076 | $50K | |
| 0250 | 1.5% | 2,494 | $41K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 797 | $39K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 3,144 | $37K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 3,230 | $36K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 8,389 | $35K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 761 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 2,294 | $31K |
| J3490 | Unclassified drugs | 1.1% | 8,296 | $30K |
| 0360 | 1.1% | 1,107 | $30K | |
| 0206 | <1% | 51 | $28K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,435 | $28K |
| 0710 | <1% | 1,607 | $26K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,406 | $26K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 491 | $25K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,400 | $24K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,701 | $22K |
| 0510 | <1% | 1,661 | $19K | |
| Z7610 | <1% | 1,432 | $18K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 249 | $17K |
| 0272 | <1% | 925 | $17K | |
| 83880 | <1% | 1,057 | $16K | |
| J2704 | Injection, propofol, 10 mg | <1% | 975 | $15K |
| 0305 | <1% | 406 | $14K | |
| 99199 | Unlisted special service, procedure or report | <1% | 112 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,466 | $12K |
| 0121 | <1% | 44 | $12K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 219 | $11K |
| 0300 | <1% | 444 | $11K | |
| 84484 | <1% | 1,857 | $11K | |
| 83735 | <1% | 3,521 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 905 | $10K |
| 85730 | <1% | 2,279 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 546 | $10K |
| 83690 | <1% | 2,099 | $9K | |
| 0306 | <1% | 397 | $8K | |
| 81001 | <1% | 3,411 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 681 | $8K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,611 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,478 | $8K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,731 | $8K |
| 0730 | <1% | 191 | $7K | |
| 81025 | <1% | 1,908 | $7K | |
| 85610 | <1% | 2,346 | $7K | |
| 87497 | <1% | 582 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 828 | $7K |
| 0320 | <1% | 191 | $7K | |
| 73562 | <1% | 513 | $7K | |
| 80197 | <1% | 1,588 | $6K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 188 | $5K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 925 | $5K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,841 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 149 | $5K |
| 87040 | <1% | 509 | $5K | |
| 0420 | <1% | 210 | $5K | |
| 83605 | <1% | 736 | $5K | |
| 0270 | <1% | 1,454 | $4K | |
| 0258 | <1% | 520 | $4K | |
| 90715 | <1% | 127 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 447 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 322 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 380 | $3K |
| 87400 | <1% | 687 | $3K | |
| 0370 | <1% | 165 | $3K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 118 | $3K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,237 | $3K |
| 87186 | <1% | 568 | $3K | |
| 0352 | <1% | 16 | $3K | |
| 0324 | <1% | 74 | $3K | |
| 0760 | <1% | 260 | $3K | |
| 20610 | <1% | 157 | $3K | |
| 0637 | <1% | 466 | $2K | |
| 94664 | <1% | 341 | $2K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 275 | $2K |
| 87077 | <1% | 590 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 126 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 59 | $2K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 15 | $2K |
| 0761 | <1% | 261 | $2K | |
| 84100 | <1% | 1,706 | $2K | |
| 72100 | <1% | 74 | $2K | |
| 93041 | <1% | 353 | $2K | |
| 73610 | <1% | 45 | $2K | |
| 73030 | <1% | 89 | $1K | |
| G0378 | Hospital observation service, per hour | <1% | 15 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,033 | $1K |
| 86850 | <1% | 455 | $1K | |
| 97162 | <1% | 90 | $1K | |
| 88312 | <1% | 213 | $1K | |
| 70486 | <1% | 12 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 479 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 340 | $1K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 44 | $1K |
| 82962 | <1% | 540 | $849.57 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 186 | $818.52 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 253 | $795.39 |
| 0636 | <1% | 118 | $787.84 | |
| 86900 | <1% | 511 | $780.23 | |
| 86901 | <1% | 513 | $754.10 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 201 | $754.04 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 401 | $625.18 |
| 82570 | <1% | 322 | $612.41 | |
| 97161 | <1% | 50 | $600.69 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 305 | $563.75 |
| 73502 | <1% | 44 | $545.99 | |
| 84439 | <1% | 84 | $498.28 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 85 | $403.83 |
| 84156 | <1% | 293 | $386.26 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 68 | $361.87 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 13 | $357.62 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 52 | $343.21 |
| 0307 | <1% | 103 | $283.19 | |
| 84702 | <1% | 29 | $280.91 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 188 | $269.01 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 76 | $259.37 |
| 71010 | <1% | 15 | $223.35 | |
| 96376 | <1% | 37 | $196.20 | |
| 73564 | <1% | 20 | $182.97 | |
| 80061 | Lipid panel | <1% | 113 | $176.36 |
| 87147 | <1% | 52 | $130.65 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26 | $124.35 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 26 | $110.05 |
| 87799 | <1% | 51 | $107.13 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 86 | $106.38 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 41 | $99.81 |
| 85379 | <1% | 12 | $87.30 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 65 | $86.06 |
| 82150 | <1% | 17 | $85.95 | |
| 88304 | <1% | 51 | $67.10 | |
| 84703 | <1% | 12 | $55.57 | |
| 82550 | <1% | 14 | $44.08 | |
| 81003 | <1% | 26 | $27.00 | |
| 80195 | <1% | 14 | $23.98 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 106 | $0.00 |
| 0483 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIS, NORMAN (DIRECTOR OF PHARMACY)